Philadelphia Eagles quarterback Jalen Hurts, celebrated for his Super Bowl win and impressive performances, faces a significant challenge due to blood clots in his lungs. His absence from the field has sparked serious inquiries regarding his medical treatment.
Hurts’ agent, Nicole Lynn, alongside the Eagles, issued a statement outlining a positive prognosis with expectations for a full recovery. Despite the life-threatening nature of pulmonary embolism, Hurts might miss the remaining season games.
Previously, Hurts was cleared to play in London against the Jacksonville Jaguars after a leg blood clot was discovered. Though he recorded 222 yards and a touchdown, the Eagles faced a 19-17 defeat. Prior to this, he battled a minor clot in his calf, resulting in a sleepless 36-hour period after doctors advised him to stay awake.
The situation escalated with Diagnoses of deep vein thrombosis (DVT) and bilateral pulmonary emboli, affecting his leg and lungs, as reported by his team and agent.
According to the CDC, DVT arises when a clot forms in deep veins, mostly in the lower limbs. Pulmonary embolism occurs when this clot travels to the lungs, posing severe dangers. CBS News chief medical correspondent, Dr. Jon LaPook, emphasized the seriousness, explaining the clot’s potential path from the leg to the heart and lungs. The implications on Hurts’ career are uncertain, but LaPook indicated treatment with blood thinners over three months, followed by further evaluation.
Controversy surrounds the Eagles’ decision to allow Hurts to play and travel internationally. Head coach Nick Sirianni deferred to the team’s medical experts, expressing trust in their assessments, yet questions remain regarding the potential risks associated.
The risks of flying with DVT were highlighted by Dr. LaPook. Blood clot risks can increase during flights due to inactivity and dehydration. Hurts played after being cleared post-diagnosis in London and immediately flew back, raising concerns about increased clotting risks.
The CDC has advised that prolonged immobility linked to long-distance travel can elevate the risk of venous thromboembolism (VTE), with associations dating back to the 1950s. Recommendations suggest waiting periods between diagnosis and flying. The International Air Transport Association and the British Thoracic Society recommend waits ranging from five days to two weeks before individuals with DVT or PE engage in flight travel.
In response, Hurts has undergone thorough evaluations by medical experts, as confirmed by the Eagles and his agent. Over the next three months, Hurts will be monitored closely under blood thinner treatment, with expectations to resume football activities once safe. The team anticipates no lasting health impacts from the condition and remains hopeful for Hurts’ strong recovery.
As Hurts stays active with the team and maintains conditioning, the Eagles express optimism for his comeback and await progress reports in anticipation of his return to play.